Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sandhaus

Showing results (81-90 of 113) with videos related to

Pageof 12
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension TrialsShuren Ma, Yong Y Lin, Jerome O Cantor, et al.
Frontiers in Immunology|July 12, 2019
Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous MycobacteriaXiyuan Bai, An Bai, Jennifer R Honda, et al.
Physiological Reports|July 17, 2024
Analysis of alpha-1-antitrypsin (AAT)-regulated, glucocorticoid receptor-dependent genes in macrophages reveals a novel host defense function of AATXiyuan Bai, Junfeng Gao, Xiaoyu Guan, et al.
Medical Hypotheses|November 26, 2020
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19Xiyuan Bai, Joseph Hippensteel, Alida Leavitt, et al.
The Patient|November 2, 2015
Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPDKristen E Holm, Richard Casaburi, Scott Cerreta, et al.
COPD|April 18, 2012
The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstructionFranck F Rahaghi, Robert A Sandhaus, Mark L Brantly, et al.
Lancet (London, England)|June 1, 2015
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trialKenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the AdultRobert A Sandhaus, Gerard Turino, Mark L Brantly, et al.
Respiratory Medicine|April 27, 2021
A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacyJerome O Cantor, Shuren Ma, Xingjian Liu, et al.
British Journal of Clinical Pharmacology|June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiencyMichael A Tortorici, James A Rogers, Oliver Vit, et al.
Pageof 12

Showing results (81-90 of 113) with videos related to

Sort By:
Pageof 12
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension TrialsShuren Ma, Yong Y Lin, Jerome O Cantor, et al.
Frontiers in Immunology|July 12, 2019
Alpha-1-Antitrypsin Enhances Primary Human Macrophage Immunity Against Non-tuberculous MycobacteriaXiyuan Bai, An Bai, Jennifer R Honda, et al.
Physiological Reports|July 17, 2024
Analysis of alpha-1-antitrypsin (AAT)-regulated, glucocorticoid receptor-dependent genes in macrophages reveals a novel host defense function of AATXiyuan Bai, Junfeng Gao, Xiaoyu Guan, et al.
Medical Hypotheses|November 26, 2020
Hypothesis: Alpha-1-antitrypsin is a promising treatment option for COVID-19Xiyuan Bai, Joseph Hippensteel, Alida Leavitt, et al.
The Patient|November 2, 2015
Patient Involvement in the Design of a Patient-Centered Clinical Trial to Promote Adherence to Supplemental Oxygen Therapy in COPDKristen E Holm, Richard Casaburi, Scott Cerreta, et al.
COPD|April 18, 2012
The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstructionFranck F Rahaghi, Robert A Sandhaus, Mark L Brantly, et al.
Lancet (London, England)|June 1, 2015
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trialKenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|August 30, 2017
The Diagnosis and Management of Alpha-1 Antitrypsin Deficiency in the AdultRobert A Sandhaus, Gerard Turino, Mark L Brantly, et al.
Respiratory Medicine|April 27, 2021
A 28-day clinical trial of aerosolized hyaluronan in alpha-1 antiprotease deficiency COPD using desmosine as a surrogate marker for drug efficacyJerome O Cantor, Shuren Ma, Xingjian Liu, et al.
British Journal of Clinical Pharmacology|June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiencyMichael A Tortorici, James A Rogers, Oliver Vit, et al.
Pageof 12